Literature DB >> 19716812

The binding of C-reactive protein, in the presence of phosphoethanolamine, to low-density lipoproteins is due to phosphoethanolamine-generated acidic pH.

Sanjay K Singh, David J Hammond, Bradley W Beeler, Alok Agrawal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19716812      PMCID： PMC2775138          DOI： 10.1016/j.cca.2009.08.013

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  3 in total

1.  Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; David J Hammond; Antonio E Rusiñol; Lawrence A Potempa; Alok Agrawal
Journal:  Clin Chim Acta       Date:  2009-06-21       Impact factor: 3.786

2.  Phosphoethanolamine-complexed C-reactive protein: a pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Deborah C Prayther; Jonathan P Moorman; Antonio E Rusiñol; Alok Agrawal
Journal:  Clin Chim Acta       Date:  2008-04-27       Impact factor: 3.786

3.  C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Deborah C Prayther; Jonathan P Moorman; Antonio E Rusiñol; Alok Agrawal
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422
  3 in total
  10 in total

1.  Functional Transformation of C-reactive Protein by Hydrogen Peroxide.

Authors:  Sanjay K Singh; Avinash Thirumalai; Asmita Pathak; Donald N Ngwa; Alok Agrawal
Journal:  J Biol Chem       Date:  2017-01-17       Impact factor: 5.157

2.  Exposing a hidden functional site of C-reactive protein by site-directed mutagenesis.

Authors:  Sanjay K Singh; Avinash Thirumalai; David J Hammond; Michael K Pangburn; Vinod K Mishra; David A Johnson; Antonio E Rusiñol; Alok Agrawal
Journal:  J Biol Chem       Date:  2011-12-09       Impact factor: 5.157

3.  Identification of acidic pH-dependent ligands of pentameric C-reactive protein.

Authors:  David J Hammond; Sanjay K Singh; James A Thompson; Bradley W Beeler; Antonio E Rusiñol; Michael K Pangburn; Lawrence A Potempa; Alok Agrawal
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

4.  Atherosclerosis-related functions of C-reactive protein.

Authors:  Alok Agrawal; David J Hammond; Sanjay K Singh
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2010-12-01

5.  Structurally Altered, Not Wild-Type, Pentameric C-Reactive Protein Inhibits Formation of Amyloid-β Fibrils.

Authors:  Donald N Ngwa; Alok Agrawal
Journal:  J Immunol       Date:  2022-08-17       Impact factor: 5.426

6.  Computational analysis of C-reactive protein for assessment of molecular dynamics and interaction properties.

Authors:  Chiranjib Chakraborty; Alok Agrawal
Journal:  Cell Biochem Biophys       Date:  2013-11       Impact factor: 2.194

7.  Human Pentraxins Bind to Misfolded Proteins and Inhibit Production of Type I Interferon Induced by Nucleic Acid-Containing Amyloid.

Authors:  Stephanie M Dorta-Estremera; Wei Cao
Journal:  J Clin Cell Immunol       Date:  2015-06-23

Review 8.  C-Reactive Protein: An In-Depth Look into Structure, Function, and Regulation.

Authors:  Juan Salazar; María Sofía Martínez; Mervin Chávez-Castillo; Victoria Núñez; Roberto Añez; Yaquelin Torres; Alexandra Toledo; Maricarmen Chacín; Carlos Silva; Enrique Pacheco; Joselyn Rojas; Valmore Bermúdez
Journal:  Int Sch Res Notices       Date:  2014-12-15

Review 9.  Recognition functions of pentameric C-reactive protein in cardiovascular disease.

Authors:  Alok Agrawal; Toh B Gang; Antonio E Rusiñol
Journal:  Mediators Inflamm       Date:  2014-05-19       Impact factor: 4.711

Review 10.  Functionality of C-Reactive Protein for Atheroprotection.

Authors:  Sanjay K Singh; Alok Agrawal
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.